Skip to content

Effects of a preventive mindfulness intervention on perceived stress and anticipatory anxiety before first clinical training in nursing students: A preregistered randomized controlled trial

Hanae Tainaka, Sachiko Nagaya, Taeko Muramatsu, Jun Inoue, Satoshi Tanaka

Research Square October 22, 2026 preprint DOI: 10.21203/rs.3.rs-11214873/v1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Preregistered
Sample size 29
Population Nursing students facing their first clinical training placement
Intervention Mindfulness meditation program
Duration 6-week program; assessments at baseline, pre-, mid-, and post-clinical training
Measures PSS-10, STAI, BDI-II, PSQI, MAAS
Topics Anxiety Meditation
Key findings The mindfulness program did not significantly reduce perceived stress, the primary outcome. State anxiety increased sharply in controls before first clinical training, while the intervention group showed no such increase and had significantly lower state anxiety at the pre-clinical assessment (d = 0.99). No significant effects were found for trait anxiety, depressive symptoms, sleep quality, or mindful awareness.

Abstract

Abstract Background Clinical training is a significant stressor for nursing students, and those facing their first placement are particularly vulnerable. This preregistered randomized controlled trial (RCT) evaluated whether a 6-week mindfulness program delivered before first clinical training could prevent stress and anxiety.

Methods: Twenty-nine nursing students were randomly assigned to the intervention (n = 15) or control (n = 14) group; 27 completed the study (intervention: n = 13, control: n = 14). The intervention group received a 6-week mindfulness meditation program; controls received standard curriculum only. Perceived stress (PSS-10) was the primary outcome; anxiety (STAI), depression (BDI-II), sleep quality (PSQI), and mindful awareness (MAAS) were secondary outcomes, assessed at baseline, pre-, mid-, and post-clinical training. Each outcome was analyzed using two-way repeated measures analysis of variance, followed by Bonferroni-corrected between-group t-tests when the group × time interaction was significant.

Results: The primary outcome, perceived stress, did not show a significant intervention effect (F(3, 75) = 0.41, p = .747). Among secondary outcomes, a significant group × time interaction was observed for state anxiety (F(3, 75) = 5.58, p = .002, ηp² = 0.182). The control group showed a sharp increase in state anxiety from baseline to the pre-clinical assessment, indicating anticipatory anxiety before first clinical training. The intervention group showed no such increase, with significantly lower state anxiety than controls at the pre-clinical assessment (d = 0.99, one-tailed Bonferroni-corrected p = .033). No significant effects were observed for trait anxiety, depressive symptoms, sleep quality, or mindful awareness.

Conclusions: In this RCT, the primary outcome of perceived stress was not significantly reduced by the mindfulness intervention. However, the findings indicate that nursing students experience substantial anticipatory anxiety before first clinical placement and suggest that a preventive mindfulness program can attenuate this anticipatory state anxiety. Future research should examine booster sessions during clinical training and evaluate effects in more diverse populations.

Trial Registration: Japan Registry of Clinical Trials (jRCT), jRCT1040240204. Registered 25 March 2025.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics